Laboratorios Farmaceuticos RoviLABFF 93 3-Year Book Growth Rate is 9.40% as of Mar. 2026, which is 40% below its 10-year median of 15.60. GuruFocus rates LABFF with a GF Score™ of 93/100 and a GF Value™ of $82.42. The stock has 1 warning sign investors should review. Among 912 Drug Manufacturers companies, Laboratorios Farmaceuticos Rovi ranks better than 68.09% on this metric.
During the past 12 months, Laboratorios Farmaceuticos Rovi's average Book Value per Share Growth Rate was 14.20% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 9.40% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 12.50% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 15.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Laboratorios Farmaceuticos Rovi was 50.20% per year. The lowest was 6.80% per year. And the median was 15.60% per year.
Laboratorios Farmaceuticos Rovi (OTCPK:LABFF) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Laboratorios Farmaceuticos Rovi 3-Year Book Growth Rate Related Terms
LABFF vs ZTS, UTHR, VTRS: 3-Year Book Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorios Farmaceuticos Rovi's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratorios Farmaceuticos Rovi 3-Year Book Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Laboratorios Farmaceuticos Rovi's 3-Year Book Growth Rate falls into.
Laboratorios Farmaceuticos Rovi 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 9.40% mean?
Laboratorios Farmaceuticos Rovi (LABFF) has a 3-Year Book Growth Rate of 9.40% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Laboratorios Farmaceuticos Rovi and its competitors. This is 40% below median its historical median of 15.60. Over the past decade, Laboratorios Farmaceuticos Rovi's 3-Year Book Growth Rate has ranged from 6.80 to 50.20. According to the industry distribution chart, Laboratorios Farmaceuticos Rovi ranks #291 out of 912 companies in the Drug Manufacturers industry, placing it in the top 31.9%.
Is Laboratorios Farmaceuticos Rovi's 3-Year Book Growth Rate too high?
Laboratorios Farmaceuticos Rovi's current 3-Year Book Growth Rate of 9.40% is 40% below median its 10-year median of 15.60. Over the past 10 years, this metric has ranged from a low of 6.80 to a high of 50.20. The Drug Manufacturers industry median 3-Year Book Growth Rate is 4.75. Laboratorios Farmaceuticos Rovi's value of 9.40% is 97.9% above this industry median. Based on the distribution chart, Laboratorios Farmaceuticos Rovi ranks #291 out of 912 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Laboratorios Farmaceuticos Rovi has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Laboratorios Farmaceuticos Rovi's 3-Year Book Growth Rate compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Laboratorios Farmaceuticos Rovi ranks #291 out of 912 companies for 3-Year Book Growth Rate. This puts Laboratorios Farmaceuticos Rovi in the upper half of its industry. The industry median 3-Year Book Growth Rate is 4.75. Laboratorios Farmaceuticos Rovi's value of 9.40% is 97.9% above this benchmark. Historically, Laboratorios Farmaceuticos Rovi's own 3-Year Book Growth Rate has ranged from 6.80 to 50.20 over the past decade. While the company's 10-year median is 15.60 vs. the industry median of 4.75, Laboratorios Farmaceuticos Rovi has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Drug Manufacturers company?
The median 3-Year Book Growth Rate among Drug Manufacturers companies is 4.75, based on 912 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laboratorios Farmaceuticos Rovi's current 3-Year Book Growth Rate of 9.40% is 97.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Laboratorios Farmaceuticos Rovi and its competitors. For the Drug Manufacturers industry, the median 3-Year Book Growth Rate is 4.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laboratorios Farmaceuticos Rovi's current 3-Year Book Growth Rate is 9.40%, which is 40% below median its own 10-year median of 15.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorios Farmaceuticos Rovi stock overvalued right now?
Laboratorios Farmaceuticos Rovi (LABFF) has a current 3-Year Book Growth Rate of 9.40%. The stock's GF Value™ is $82.42, compared to a current price of $90.61 — trading 9.9% above its estimated fair value. The current 3-Year Book Growth Rate is 9.40%, which is 40% below median its 10-year median of 15.60 and 97.9% above the Drug Manufacturers industry median of 4.75. Laboratorios Farmaceuticos Rovi's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Laboratorios Farmaceuticos Rovi (LABFF), the current 3-Year Book Growth Rate is 9.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Laboratorios Farmaceuticos Rovi (LABFF) Overvalued in 2026?
Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi stock appears to be overvalued.
The current stock price of $90.61 is trading 9.9% above its estimated GF Value™ of $82.42.
Key valuation signals for LABFF:
3-Year Book Growth Rate: 9.40% (40% below median its 10-year median of 15.60)
GF Value™: $82.42 vs. price of $90.61 (9.9% above fair value)
Industry Position: 97.9% above the Drug Manufacturers median (#291 of 912)
No single metric tells the full story. See the LABFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Laboratorios Farmaceuticos Rovi Business Description
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.
93GF Score
Get the complete analysis for LABFF
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LABFF has been successfully added to your 